project id: TCGA-CESC; case submitter id: TCGA-MY-A913; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.85; concentration: 0.17; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.59; rna integrity number: 8.8; age at index: 28; days to birth: -10379; ethnicity: hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1985; age at diagnosis: 10379; ajcc pathologic m: M1; ajcc pathologic n: N0; ajcc pathologic t: Tis; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 524.0; figo stage: Stage IIA; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 107; days to sample procurement: 0; initial weight: 210.0; portion submitter id: TCGA-MY-A913-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 10.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;